West Pharmaceutical Services, Inc. (WST)
342.55
-0.08
(-0.02%)
USD |
NYSE |
Sep 03, 16:00
342.55
0.00 (0.00%)
After-Hours: 18:26
West Pharmaceutical Services Research and Development Expense (TTM) : 74.40M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 74.40M |
| March 31, 2026 | 73.80M |
| December 31, 2025 | 74.30M |
| September 30, 2025 | 71.00M |
| June 30, 2025 | 69.40M |
| March 31, 2025 | 67.80M |
| December 31, 2024 | 69.10M |
| September 30, 2024 | 69.00M |
| June 30, 2024 | 69.90M |
| March 31, 2024 | 68.90M |
| December 31, 2023 | 68.40M |
| September 30, 2023 | 65.90M |
| June 30, 2023 | 63.10M |
| March 31, 2023 | 61.00M |
| December 31, 2022 | 58.50M |
| September 30, 2022 | 56.30M |
| June 30, 2022 | 55.80M |
| March 31, 2022 | 55.20M |
| December 31, 2021 | 52.80M |
| September 30, 2021 | 52.00M |
| June 30, 2021 | 51.40M |
| March 31, 2021 | 48.40M |
| December 31, 2020 | 46.90M |
| September 30, 2020 | 44.20M |
| June 30, 2020 | 41.00M |
| Date | Value |
|---|---|
| March 31, 2020 | 39.80M |
| December 31, 2019 | 38.90M |
| September 30, 2019 | 38.50M |
| June 30, 2019 | 39.30M |
| March 31, 2019 | 40.50M |
| December 31, 2018 | 40.30M |
| September 30, 2018 | 40.20M |
| June 30, 2018 | 39.20M |
| March 31, 2018 | 38.40M |
| December 31, 2017 | 39.10M |
| September 30, 2017 | 39.00M |
| June 30, 2017 | 38.90M |
| March 31, 2017 | 37.70M |
| December 31, 2016 | 36.80M |
| September 30, 2016 | 37.20M |
| June 30, 2016 | 36.70M |
| March 31, 2016 | 36.00M |
| December 31, 2015 | 34.10M |
| September 30, 2015 | 31.90M |
| June 30, 2015 | 33.00M |
| March 31, 2015 | 34.80M |
| December 31, 2014 | 37.30M |
| September 30, 2014 | 39.20M |
| June 30, 2014 | 39.20M |
| March 31, 2014 | 38.80M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Globus Medical, Inc. | 147.06M |
| Hinge Health, Inc. | 129.07M |
| Baxter International, Inc. | 480.00M |
| The Cooper Cos., Inc. | 172.80M |
| Becton, Dickinson & Co. | 1.135B |